Hang Wang, Rui Wang, Le Cao, William Robert Kwapong, Ruishan Liu, Fayun Hu, Bo Wu
Introduction: We aimed to explore the difference in choroidal vascular parameters using swept-source optical coherence tomography (SS-OCT) in patients with idiopathic intracranial hypertension (IIH) compared to controls. We also explored the ability of the choroidal parameters to reflect elevated intracranial pressure (ICP) in patients with IIH.
Methods: This observational study recruited patients diagnosed with IIH and healthy controls. A lumbar puncture was performed for ICP measurement. All the participants underwent OCT examinations. The choroid was automatically segmented and imaged by the OCT tool. The parafoveal choroidal vascular volume (CVV) and choroidal vascular index (CVI) were calculated in 3 mm annulus and 6 mm annulus.
Results: A total of 80 patients with IIH (34.67 ± 11.00 years; 37.50% males) and 92 controls (34.50 ± 12.08 years; 36.96% males) were included in the final analysis. Patients with IIH had higher BMI (< 0.001) and poor visual acuity (< 0.001) compared with controls. Patients with IIH demonstrated significantly lower parafovea CVI in both annuluses (p = 0.003 for 3 mm annulus, p = 0.001 for 6 mm annulus) compared to controls. Mean parafovea CVI in both annuluses was significantly correlated with ICP level (p = 0.014 for 3 mm annulus, p = 0.015 for 6 mm annulus). The combination of CVV and CVI in a 6 mm annulus demonstrated the highest diagnostic value with a mean AUC of 0.818.
Conclusion: CVI may serve as a potential marker for identifying IIH and reflecting ICP changes.
{"title":"Decreased Choroidal Vascular Index in Idiopathic Intracranial Hypertension.","authors":"Hang Wang, Rui Wang, Le Cao, William Robert Kwapong, Ruishan Liu, Fayun Hu, Bo Wu","doi":"10.1002/brb3.70258","DOIUrl":"10.1002/brb3.70258","url":null,"abstract":"<p><strong>Introduction: </strong>We aimed to explore the difference in choroidal vascular parameters using swept-source optical coherence tomography (SS-OCT) in patients with idiopathic intracranial hypertension (IIH) compared to controls. We also explored the ability of the choroidal parameters to reflect elevated intracranial pressure (ICP) in patients with IIH.</p><p><strong>Methods: </strong>This observational study recruited patients diagnosed with IIH and healthy controls. A lumbar puncture was performed for ICP measurement. All the participants underwent OCT examinations. The choroid was automatically segmented and imaged by the OCT tool. The parafoveal choroidal vascular volume (CVV) and choroidal vascular index (CVI) were calculated in 3 mm annulus and 6 mm annulus.</p><p><strong>Results: </strong>A total of 80 patients with IIH (34.67 ± 11.00 years; 37.50% males) and 92 controls (34.50 ± 12.08 years; 36.96% males) were included in the final analysis. Patients with IIH had higher BMI (< 0.001) and poor visual acuity (< 0.001) compared with controls. Patients with IIH demonstrated significantly lower parafovea CVI in both annuluses (p = 0.003 for 3 mm annulus, p = 0.001 for 6 mm annulus) compared to controls. Mean parafovea CVI in both annuluses was significantly correlated with ICP level (p = 0.014 for 3 mm annulus, p = 0.015 for 6 mm annulus). The combination of CVV and CVI in a 6 mm annulus demonstrated the highest diagnostic value with a mean AUC of 0.818.</p><p><strong>Conclusion: </strong>CVI may serve as a potential marker for identifying IIH and reflecting ICP changes.</p>","PeriodicalId":9081,"journal":{"name":"Brain and Behavior","volume":"15 1","pages":"e70258"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11726707/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142944486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Immune system modulation has been shown to have a significant impact on attention deficit hyperactivity disorder (ADHD). Mendelian randomization (MR) analysis was used in this study to investigate the potential role of different immune cells in the development of ADHD to provide therapy and preventative alternatives.
Methods: In this study, 731 immune cells and the risk of ADHD were examined using publicly accessible genetic data and a two-sample MR analysis. Included were four different types of immunological profiles: determinate cells (DC), proportional cells (PC), median brightness level (MBL), and morphological characteristics (MA). It was discovered that single-nucleotide polymorphisms (SNPs) are linked to ADHD. To evaluate the dependability of the results, we conducted sensitivity analysis (heterogeneity and pleiotropy) and employed supplementary MR techniques, such as the inverse variance weighted (IVW) and MR-Egger. Graphs are used to display the final findings of the pertinent analyses.
Results: Following MR analysis, immune cells associated with a few low p value phenotypes may influence ADHD, and these immune cells may serve as an inspiration for clinical treatment practices that aim to prevent and cure ADHD. Immune cell phenotypes that may both increase and worsen the likelihood of having ADHD were identified by IVW results. These included CD27 on memory B cells (OR = 1.066, 95% CI = 1.024-1.109, p = 2E-3) and CD27 on IgD-CD38- (OR = 1.059, 95% CI = 1.018-1.103, p = 5E-3), among others. Immune cell phenotypes that may act as a safeguard against ADHD included CD3 on resting Treg (OR = 0.925, 95% CI = 0.888-0.963, p = 1.5E-4) and SSC-A on monocytes (OR = 0.951, 95% CI = 0.924-0.980, p = 8.5E-4), among others. The primary findings and the outcomes of the sensitivity analysis matched.
Conclusions: This study provides a broad theoretical foundation for the development of immune-oriented therapeutic strategies in future clinical practice by demonstrating a potential genetic relationship between immune cells and ADHD. This study also advances our understanding of how to use the immune pathway to prevent and treat ADHD.
背景:免疫系统调节已被证明对注意缺陷多动障碍(ADHD)有重要影响。本研究使用孟德尔随机化(MR)分析来研究不同免疫细胞在ADHD发展中的潜在作用,以提供治疗和预防方案。方法:在这项研究中,使用可公开获取的遗传数据和两样本MR分析,检查了731个免疫细胞和ADHD的风险。包括四种不同类型的免疫图谱:确定细胞(DC)、比例细胞(PC)、中位亮度水平(MBL)和形态特征(MA)。人们发现单核苷酸多态性(snp)与多动症有关。为了评估结果的可靠性,我们进行了敏感性分析(异质性和多效性),并采用了补充MR技术,如逆方差加权(IVW)和MR- egger。图表用于显示相关分析的最终结果。结果:通过MR分析,与少数低p值表型相关的免疫细胞可能影响ADHD,这些免疫细胞可能为旨在预防和治疗ADHD的临床治疗实践提供灵感。免疫细胞表型可能增加或加重患ADHD的可能性,这是通过IVW结果确定的。其中包括记忆B细胞上的CD27 (OR = 1.066, 95% CI = 1.024-1.109, p = e2 -3)和IgD-CD38-上的CD27 (OR = 1.059, 95% CI = 1.018-1.103, p = 5E-3)等。可能作为预防ADHD的免疫细胞表型包括静息Treg上的CD3 (OR = 0.925, 95% CI = 0.888-0.963, p = 1.5E-4)和单核细胞上的SSC-A (OR = 0.951, 95% CI = 0.924-0.980, p = 8.5E-4)等。初步结果与敏感性分析结果相符。结论:本研究通过证明免疫细胞与ADHD之间潜在的遗传关系,为未来临床实践中免疫导向治疗策略的发展提供了广泛的理论基础。这项研究也促进了我们对如何使用免疫途径来预防和治疗多动症的理解。
{"title":"Assessing the Causal Relationship Between Various Immune Cells and Attention Deficit Hyperactivity Disorder: Mendelian Randomization Study.","authors":"Qian Ge, Zhongyan Li, Weijing Meng, Chen Cai, Mengdi Qiu, Yafei Liu, Haibo Zhu","doi":"10.1002/brb3.70280","DOIUrl":"10.1002/brb3.70280","url":null,"abstract":"<p><strong>Background: </strong>Immune system modulation has been shown to have a significant impact on attention deficit hyperactivity disorder (ADHD). Mendelian randomization (MR) analysis was used in this study to investigate the potential role of different immune cells in the development of ADHD to provide therapy and preventative alternatives.</p><p><strong>Methods: </strong>In this study, 731 immune cells and the risk of ADHD were examined using publicly accessible genetic data and a two-sample MR analysis. Included were four different types of immunological profiles: determinate cells (DC), proportional cells (PC), median brightness level (MBL), and morphological characteristics (MA). It was discovered that single-nucleotide polymorphisms (SNPs) are linked to ADHD. To evaluate the dependability of the results, we conducted sensitivity analysis (heterogeneity and pleiotropy) and employed supplementary MR techniques, such as the inverse variance weighted (IVW) and MR-Egger. Graphs are used to display the final findings of the pertinent analyses.</p><p><strong>Results: </strong>Following MR analysis, immune cells associated with a few low p value phenotypes may influence ADHD, and these immune cells may serve as an inspiration for clinical treatment practices that aim to prevent and cure ADHD. Immune cell phenotypes that may both increase and worsen the likelihood of having ADHD were identified by IVW results. These included CD27 on memory B cells (OR = 1.066, 95% CI = 1.024-1.109, p = 2E-3) and CD27 on IgD<sup>-</sup>CD38<sup>-</sup> (OR = 1.059, 95% CI = 1.018-1.103, p = 5E-3), among others. Immune cell phenotypes that may act as a safeguard against ADHD included CD3 on resting Treg (OR = 0.925, 95% CI = 0.888-0.963, p = 1.5E-4) and SSC-A on monocytes (OR = 0.951, 95% CI = 0.924-0.980, p = 8.5E-4), among others. The primary findings and the outcomes of the sensitivity analysis matched.</p><p><strong>Conclusions: </strong>This study provides a broad theoretical foundation for the development of immune-oriented therapeutic strategies in future clinical practice by demonstrating a potential genetic relationship between immune cells and ADHD. This study also advances our understanding of how to use the immune pathway to prevent and treat ADHD.</p>","PeriodicalId":9081,"journal":{"name":"Brain and Behavior","volume":"15 1","pages":"e70280"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11743990/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142999930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tobias Meindl, Alexander Hapfelmeier, Tobias Mantel, Angela Jochim, Jonas Deppe, Silke Zwirner, Jan S Kirschke, Yong Li, Bernhard Haslinger
Background: While automated methods for differential diagnosis of parkinsonian syndromes based on MRI imaging have been introduced, their implementation in clinical practice still underlies considerable challenges.
Objective: To assess whether the performance of classifiers based on imaging derived biomarkers is improved with the addition of basic clinical information and to provide a practical solution to address the insecurity of classification results due to the uncertain clinical diagnosis they are based on.
Methods: Retro- and prospectively collected data from multimodal MRI and standardized clinical datasets of 229 patients with PD (n = 167), PSP (n = 44), or MSA (n = 18) underwent multinomial classification in a benchmark study comparing the performance of nine machine learning methods. A predictor space of imaging variables, either with or without clinical information, was investigated. Classification results were assessed using multiclass AUCs. Individual predicted probabilities were visualized to address diagnostic uncertainty.
Results: Clinical diagnosis was accurately confirmed using machine learning models with only small differences when using imaging and clinical signs versus imaging variables only (expected multiclass AUC of 0.95 vs. 0.92). Still, multinomial classification is hampered by imbalanced class frequencies. The most discriminatory variables were responsiveness to levodopa, vertical gaze palsy, and the volumes of subcortical structures, including the red nucleus.
Conclusion: Machine-learning-assisted classification of MR-imaging biomarkers gathered in routine care can assist in the diagnosis of parkinsonian syndromes as part of the diagnostic workup. We provide a visual method that aids the interpretation of neuroimaging-based classification results of the three main parkinsonian syndromes, improving clinical interpretability.
{"title":"Assisted Parkinsonism Diagnosis Using Multimodal MRI-The Role of Clinical Insights.","authors":"Tobias Meindl, Alexander Hapfelmeier, Tobias Mantel, Angela Jochim, Jonas Deppe, Silke Zwirner, Jan S Kirschke, Yong Li, Bernhard Haslinger","doi":"10.1002/brb3.70274","DOIUrl":"10.1002/brb3.70274","url":null,"abstract":"<p><strong>Background: </strong>While automated methods for differential diagnosis of parkinsonian syndromes based on MRI imaging have been introduced, their implementation in clinical practice still underlies considerable challenges.</p><p><strong>Objective: </strong>To assess whether the performance of classifiers based on imaging derived biomarkers is improved with the addition of basic clinical information and to provide a practical solution to address the insecurity of classification results due to the uncertain clinical diagnosis they are based on.</p><p><strong>Methods: </strong>Retro- and prospectively collected data from multimodal MRI and standardized clinical datasets of 229 patients with PD (n = 167), PSP (n = 44), or MSA (n = 18) underwent multinomial classification in a benchmark study comparing the performance of nine machine learning methods. A predictor space of imaging variables, either with or without clinical information, was investigated. Classification results were assessed using multiclass AUCs. Individual predicted probabilities were visualized to address diagnostic uncertainty.</p><p><strong>Results: </strong>Clinical diagnosis was accurately confirmed using machine learning models with only small differences when using imaging and clinical signs versus imaging variables only (expected multiclass AUC of 0.95 vs. 0.92). Still, multinomial classification is hampered by imbalanced class frequencies. The most discriminatory variables were responsiveness to levodopa, vertical gaze palsy, and the volumes of subcortical structures, including the red nucleus.</p><p><strong>Conclusion: </strong>Machine-learning-assisted classification of MR-imaging biomarkers gathered in routine care can assist in the diagnosis of parkinsonian syndromes as part of the diagnostic workup. We provide a visual method that aids the interpretation of neuroimaging-based classification results of the three main parkinsonian syndromes, improving clinical interpretability.</p>","PeriodicalId":9081,"journal":{"name":"Brain and Behavior","volume":"15 1","pages":"e70274"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11743991/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142999931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Binbin Fu, Xiangyue Zhou, Xuan Zhou, Xin Li, Zhengquan Chen, Yanbin Zhang, Qing Du
Background: Transcranial magnetic stimulation (TMS) is a promising neuromodulation technique that has been widely used in neuropsychiatric disorders, but there was no evidence on its effect on the improvement attention-deficit hyperactivity disorder (ADHD).
Objective: This systematic review and meta-analysis aimed to investigate the efficacy and safety of TMS in reducing ADHD symptoms.
Method: We systematically searched four databases (PubMed, Embase, Web of Science, and Cochrane Library databases) for randomized controlled/crossover trials on the efficacy and safety of TMS on ADHD symptom improvement compared to sham rTMS or non-TMS interventions, published until September 18, 2024. Extracted data from the included studies involved patient characteristics, intervention protocols, and main outcomes. The effect size of the TMS treatment was evaluated using the standardized mean difference (SMD) with a 95% confidence interval (CI), calculated with either a random effects model or fixed effects model depending on the level of heterogeneity.
Result: Eight studies (325 ADHD patients in total) were included in this systematic review and meta-analysis. According to the core symptoms, TMS significantly improved inattention (SMD = -0.94, 95% CI = -1.33 to -0.56, p < 0.001) and hyperactivity/impulsivity (SMD = -0.98, 95% CI = -1.27 to -0.69, p < 0.001) compared to non-TMS interventions after 3-6 weeks of intervention. During the 1-month follow-up, the TMS group still demonstrated a significant improvement in inattention symptoms compared to the non-TMS group (SMD = -0.67, 95% CI = -1.06 to 0.28, p < 0.001). The total symptoms in the TMS group only showed improvement in the 1-month follow-up compared to the non-TMS group. (SMD = -0.48, 95% CI = -0.82 to -0.14, p = 0.005). Only minor adverse events were reported in the included studies, comprising headache and scalp discomfort.
Conclusion: TMS significantly improved the inattention, hyperactivity/impulsivity, and total symptom scores in ADHD patients with minor adverse events. Future research should focus on the association between different brain regions and symptoms in ADHD patients, which is crucial for stimulation navigation in TMS interventions. The trial is registered in PROSPERO (PROSPERO registry number: CRD42023473853).
背景:经颅磁刺激(Transcranial magnetic stimulation, TMS)是一种很有前途的神经调节技术,已广泛应用于神经精神疾病,但其对注意力缺陷多动障碍(attention-deficit hyperactivity disorder, ADHD)的改善效果尚无证据。目的:本系统综述和荟萃分析旨在探讨经颅磁刺激减轻ADHD症状的有效性和安全性。方法:我们系统地检索了四个数据库(PubMed、Embase、Web of Science和Cochrane Library数据库),检索了截至2024年9月18日发表的随机对照/交叉试验,比较经颅刺激与假性经颅刺激或非经颅刺激干预对ADHD症状改善的有效性和安全性。从纳入的研究中提取的数据包括患者特征、干预方案和主要结果。采用标准化平均差(SMD)和95%置信区间(CI)评估经颅磁刺激治疗的效应大小,根据异质性的水平,采用随机效应模型或固定效应模型计算。结果:8项研究(共325例ADHD患者)纳入本系统综述和荟萃分析。根据核心症状,经颅磁刺激可显著改善注意力不集中(SMD = -0.94, 95% CI = -1.33 ~ -0.56, p)。结论:经颅磁刺激可显著改善轻度不良事件ADHD患者的注意力不集中、多动/冲动及总症状评分。未来的研究应关注ADHD患者不同脑区与症状之间的关联,这对经颅磁刺激干预中的刺激导航至关重要。该试验在PROSPERO注册(PROSPERO注册号:CRD42023473853)。
{"title":"Efficacy and Safety of Transcranial Magnetic Stimulation for Attention-Deficit Hyperactivity Disorder: A Systematic Review and Meta-Analysis.","authors":"Binbin Fu, Xiangyue Zhou, Xuan Zhou, Xin Li, Zhengquan Chen, Yanbin Zhang, Qing Du","doi":"10.1002/brb3.70246","DOIUrl":"10.1002/brb3.70246","url":null,"abstract":"<p><strong>Background: </strong>Transcranial magnetic stimulation (TMS) is a promising neuromodulation technique that has been widely used in neuropsychiatric disorders, but there was no evidence on its effect on the improvement attention-deficit hyperactivity disorder (ADHD).</p><p><strong>Objective: </strong>This systematic review and meta-analysis aimed to investigate the efficacy and safety of TMS in reducing ADHD symptoms.</p><p><strong>Method: </strong>We systematically searched four databases (PubMed, Embase, Web of Science, and Cochrane Library databases) for randomized controlled/crossover trials on the efficacy and safety of TMS on ADHD symptom improvement compared to sham rTMS or non-TMS interventions, published until September 18, 2024. Extracted data from the included studies involved patient characteristics, intervention protocols, and main outcomes. The effect size of the TMS treatment was evaluated using the standardized mean difference (SMD) with a 95% confidence interval (CI), calculated with either a random effects model or fixed effects model depending on the level of heterogeneity.</p><p><strong>Result: </strong>Eight studies (325 ADHD patients in total) were included in this systematic review and meta-analysis. According to the core symptoms, TMS significantly improved inattention (SMD = -0.94, 95% CI = -1.33 to -0.56, p < 0.001) and hyperactivity/impulsivity (SMD = -0.98, 95% CI = -1.27 to -0.69, p < 0.001) compared to non-TMS interventions after 3-6 weeks of intervention. During the 1-month follow-up, the TMS group still demonstrated a significant improvement in inattention symptoms compared to the non-TMS group (SMD = -0.67, 95% CI = -1.06 to 0.28, p < 0.001). The total symptoms in the TMS group only showed improvement in the 1-month follow-up compared to the non-TMS group. (SMD = -0.48, 95% CI = -0.82 to -0.14, p = 0.005). Only minor adverse events were reported in the included studies, comprising headache and scalp discomfort.</p><p><strong>Conclusion: </strong>TMS significantly improved the inattention, hyperactivity/impulsivity, and total symptom scores in ADHD patients with minor adverse events. Future research should focus on the association between different brain regions and symptoms in ADHD patients, which is crucial for stimulation navigation in TMS interventions. The trial is registered in PROSPERO (PROSPERO registry number: CRD42023473853).</p>","PeriodicalId":9081,"journal":{"name":"Brain and Behavior","volume":"15 1","pages":"e70246"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11743978/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142999979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Psychotherapeutic memory plays an important role in maintaining therapeutic effects; however, the neural mechanisms of therapeutic metaphor promoting long-term memory were still unknown.
Objective: This study used metaphorical micro-counseling dialog scenarios to investigate the memory effect of therapeutic metaphor and correlated neural mechanisms.
Methods: At first, 31 participants read a mental distress problem, followed by a metaphorical or a literal solution, while undergoing functional magnetic resonance imaging scanning during the encoding phase. One week later, a recognition memory test was performed outside the scanner.
Results: The results revealed that metaphorical solutions were associated with higher insight experiences and better memory performance than literal solutions. Greater activations were observed in the multiple memory systems, including episodic (parahippocampal gyrus, hippocampus, and thalamus), emotional (amygdala), and procedural/implicit (caudate, putamen, and cerebellum), in contrast to later remembered versus later forgotten based on the gap between metaphorical and literal solutions. Insightfulness and activities of the hippocampus, caudate, and cerebellum could predict memory performance.
Conclusions: These findings indicated that multiple memory systems are involved in successful memory encoding of therapeutic metaphors; this suggested that incorporating metaphors into psychotherapy practices could lead to better retention of therapeutic information and improve clinical outcomes compared to literal psychotherapy.
{"title":"Therapeutic Metaphors Enhance Memory Systems in Mental Health Contexts.","authors":"Fei Yu, Zhijie Zhang, Wencai Zhang","doi":"10.1002/brb3.70270","DOIUrl":"10.1002/brb3.70270","url":null,"abstract":"<p><strong>Background: </strong>Psychotherapeutic memory plays an important role in maintaining therapeutic effects; however, the neural mechanisms of therapeutic metaphor promoting long-term memory were still unknown.</p><p><strong>Objective: </strong>This study used metaphorical micro-counseling dialog scenarios to investigate the memory effect of therapeutic metaphor and correlated neural mechanisms.</p><p><strong>Methods: </strong>At first, 31 participants read a mental distress problem, followed by a metaphorical or a literal solution, while undergoing functional magnetic resonance imaging scanning during the encoding phase. One week later, a recognition memory test was performed outside the scanner.</p><p><strong>Results: </strong>The results revealed that metaphorical solutions were associated with higher insight experiences and better memory performance than literal solutions. Greater activations were observed in the multiple memory systems, including episodic (parahippocampal gyrus, hippocampus, and thalamus), emotional (amygdala), and procedural/implicit (caudate, putamen, and cerebellum), in contrast to later remembered versus later forgotten based on the gap between metaphorical and literal solutions. Insightfulness and activities of the hippocampus, caudate, and cerebellum could predict memory performance.</p><p><strong>Conclusions: </strong>These findings indicated that multiple memory systems are involved in successful memory encoding of therapeutic metaphors; this suggested that incorporating metaphors into psychotherapy practices could lead to better retention of therapeutic information and improve clinical outcomes compared to literal psychotherapy.</p>","PeriodicalId":9081,"journal":{"name":"Brain and Behavior","volume":"15 1","pages":"e70270"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11743976/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143000044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abraham Nunes, Selena Singh, Anouar Khayachi, Shani Stern, Thomas Trappenberg, Martin Alda
Introduction: Patients with bipolar disorder (BD) demonstrate episodic memory deficits, which may be hippocampal-dependent and may be attenuated in lithium responders. Induced pluripotent stem cell-derived CA3 pyramidal cell-like neurons show significant hyperexcitability in lithium-responsive BD patients, while lithium nonresponders show marked variance in hyperexcitability. We hypothesize that this variable excitability will impair episodic memory recall, as assessed by cued retrieval (pattern completion) within a computational model of the hippocampal CA3.
Methods: We simulated pattern completion tasks using a computational model of the CA3 with different degrees of pyramidal cell excitability variance. Since pyramidal cell excitability variance naturally leads to a mix of hyperexcitability and hypoexcitability, we also examined what fraction (hyper- vs. hypoexcitable) was predominantly responsible for pattern completion errors in our model.
Results: Pyramidal cell excitability variance impaired pattern completion (linear model β = -2.00, SE = 0.03, p < 0.001). The effect was invariant to all other parameter settings in the model. Excitability variance, specifically hyperexcitability, increased the number of spuriously active neurons, increasing false alarm rates and producing pattern completion deficits. Excessive inhibition also induces pattern completion deficits by limiting the number of correctly active neurons during pattern retrieval.
Conclusions: Excitability variance in CA3 pyramidal cell-like neurons observed in lithium nonresponders may predict pattern completion deficits in these patients. These cognitive deficits may not be fully corrected by medications that minimize excitability. Future studies should test our predictions by examining behavioral correlates of pattern completion in lithium-responsive and -nonresponsive BD patients.
双相情感障碍(BD)患者表现出情景记忆缺陷,这可能是海马依赖的,并且在锂反应者中可能会减弱。诱导多能干细胞衍生的CA3锥体细胞样神经元在锂反应性BD患者中表现出显著的高兴奋性,而锂无反应者在高兴奋性方面表现出显著差异。我们假设这种可变的兴奋性会损害情景记忆的回忆,正如海马CA3计算模型中的线索检索(模式完成)所评估的那样。方法:利用具有不同锥体细胞兴奋性变化程度的CA3计算模型模拟图案完成任务。由于锥体细胞兴奋性差异自然导致高兴奋性和低兴奋性的混合,我们还检查了在我们的模型中,哪一部分(高兴奋性和低兴奋性)是导致模式完成错误的主要原因。结果:锥体细胞兴奋性方差损害模式完成(线性模型β = -2.00, SE = 0.03, p)结论:在锂离子无反应患者中观察到的CA3锥体细胞样神经元的兴奋性方差可能预测这些患者的模式完成缺陷。这些认知缺陷可能无法通过减少兴奋性的药物得到完全纠正。未来的研究应该通过检查锂反应性和非反应性双相障碍患者模式完成的行为相关性来验证我们的预测。
{"title":"The Impact of Electrophysiological Diversity on Pattern Completion in Lithium Nonresponsive Bipolar Disorder: A Computational Modeling Approach.","authors":"Abraham Nunes, Selena Singh, Anouar Khayachi, Shani Stern, Thomas Trappenberg, Martin Alda","doi":"10.1002/brb3.70209","DOIUrl":"https://doi.org/10.1002/brb3.70209","url":null,"abstract":"<p><strong>Introduction: </strong>Patients with bipolar disorder (BD) demonstrate episodic memory deficits, which may be hippocampal-dependent and may be attenuated in lithium responders. Induced pluripotent stem cell-derived CA3 pyramidal cell-like neurons show significant hyperexcitability in lithium-responsive BD patients, while lithium nonresponders show marked variance in hyperexcitability. We hypothesize that this variable excitability will impair episodic memory recall, as assessed by cued retrieval (pattern completion) within a computational model of the hippocampal CA3.</p><p><strong>Methods: </strong>We simulated pattern completion tasks using a computational model of the CA3 with different degrees of pyramidal cell excitability variance. Since pyramidal cell excitability variance naturally leads to a mix of hyperexcitability and hypoexcitability, we also examined what fraction (hyper- vs. hypoexcitable) was predominantly responsible for pattern completion errors in our model.</p><p><strong>Results: </strong>Pyramidal cell excitability variance impaired pattern completion (linear model β = -2.00, SE = 0.03, p < 0.001). The effect was invariant to all other parameter settings in the model. Excitability variance, specifically hyperexcitability, increased the number of spuriously active neurons, increasing false alarm rates and producing pattern completion deficits. Excessive inhibition also induces pattern completion deficits by limiting the number of correctly active neurons during pattern retrieval.</p><p><strong>Conclusions: </strong>Excitability variance in CA3 pyramidal cell-like neurons observed in lithium nonresponders may predict pattern completion deficits in these patients. These cognitive deficits may not be fully corrected by medications that minimize excitability. Future studies should test our predictions by examining behavioral correlates of pattern completion in lithium-responsive and -nonresponsive BD patients.</p>","PeriodicalId":9081,"journal":{"name":"Brain and Behavior","volume":"15 1","pages":"e70209"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11745123/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142999995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abdulsalam Mohammed Aleid, Faisal Alshehri, Naif Alasiri, Fatimah Alhomoud, Shouq Alsaegh, Mohammed Alrasheed, Salem Aljaddua, Ali Alasiri, Asma Boukhari, Abdulmonem Ali Alhussain, Bipin Chaurasia, Saud Nayef Aldanyowi
Background: Duloxetine, a serotonin and norepinephrine reuptake inhibitor (SNRI), is used to treat various health conditions, including major depressive disorder, generalized anxiety disorder, fibromyalgia, and off-label for chemotherapy-induced pain. We conducted this systematic review and meta-analysis aiming to test the current evidence regarding effectiveness and safety of duloxetine for postspine surgeries pain.
Methods: We searched the Cochrane Central Register of Controlled Trials, PubMed, Scopus and Web of science databases for relevant articles up to March 2024. The following search terms were Used in combination using the Boolean operators ((Duloxetine Hydrochloride) AND ((Pain, Postoperative) OR (Postoperative Period) OR (Postoperative Cognitive Complications) OR (Delayed Emergence from Anesthesia) OR (Postoperative Care) OR (spine surgery)) without time constrain for the search. Meta-analysis was performed using Review Manager (RevMan version 5.4) on the extracted outcome data that present in at least 3 of the included studies. Mean difference (MD) was used as the effect size for continuous outcomes with a 95% confidence interval (CI) or standardized mean difference (SMD) in case of different outcome reporting scales.
Results: Pooled analysis showed that duloxetine significantly reduces pain intensity after 24 h from the operation compared to placebo (SMD = -1.11, 95% CI [-2.16 to -0.07], p = 0.04) with no significant difference in pain after 2 and 48 h. Meta-analysis revealed that duloxetine shows a significant reduction in the amount of analgesic consumption after 24 h postoperative; (MD = -3.33, 95% CI [-5.53 to -1.13], p = 0.003). The analysis did not show any statistically significant difference between duloxetine and placebo in patients experiencing nausea or vomiting (RR = 1.37, 95% CI [0.62 to 3.00] CONCLUSION: The findings of this study suggest that duloxetine may be effective in reducing pain 24 h after spine surgery. Furthermore, there is a promising effect of duloxetine in treating chronic postoperative pain. However, it is important to acknowledge that further research is warranted to thoroughly evaluate the efficacy and safety of duloxetine for relieving chronic postoperative pain.
背景:度洛西汀是一种血清素和去甲肾上腺素再摄取抑制剂(SNRI),用于治疗各种健康状况,包括重度抑郁症、广泛性焦虑症、纤维肌痛和化疗引起的非适应症疼痛。我们进行了这项系统回顾和荟萃分析,旨在检验目前关于度洛西汀治疗脊柱术后疼痛的有效性和安全性的证据。方法:检索Cochrane Central Register of Controlled Trials、PubMed、Scopus和Web of science数据库,检索截止到2024年3月的相关文章。以下搜索词使用布尔运算符((盐酸度洛西汀)和((疼痛,术后)或(术后期间)或(术后认知并发症)或(麻醉延迟苏醒)或(术后护理)或(脊柱手术))组合使用,不受搜索时间限制。使用Review Manager (RevMan version 5.4)对至少3项纳入研究中提取的结果数据进行meta分析。在不同结果报告量表的情况下,使用平均差(MD)作为连续结果的效应量,95%置信区间(CI)或标准化平均差(SMD)。结果:合并分析显示,与安慰剂相比,度洛西汀可显著降低术后24 h疼痛强度(SMD = -1.11, 95% CI [-2.16 ~ -0.07], p = 0.04),术后2 h和48 h疼痛无显著差异。meta分析显示,度洛西汀可显著降低术后24 h镇痛药的用量;(MD = -3.33, 95% CI [-5.53 - -1.13], p = 0.003)。分析未显示度洛西汀与安慰剂在恶心或呕吐患者中的差异有统计学意义(RR = 1.37, 95% CI[0.62 ~ 3.00])。结论:本研究结果提示度洛西汀可有效减轻脊柱手术后24小时疼痛。此外,度洛西汀在治疗慢性术后疼痛方面也有很好的效果。然而,重要的是要认识到,需要进一步的研究来彻底评估度洛西汀缓解术后慢性疼痛的有效性和安全性。
{"title":"Efficacy of Duloxetine for Postspine Surgery Pain: A Systematic Review and Meta-Analysis.","authors":"Abdulsalam Mohammed Aleid, Faisal Alshehri, Naif Alasiri, Fatimah Alhomoud, Shouq Alsaegh, Mohammed Alrasheed, Salem Aljaddua, Ali Alasiri, Asma Boukhari, Abdulmonem Ali Alhussain, Bipin Chaurasia, Saud Nayef Aldanyowi","doi":"10.1002/brb3.70217","DOIUrl":"10.1002/brb3.70217","url":null,"abstract":"<p><strong>Background: </strong>Duloxetine, a serotonin and norepinephrine reuptake inhibitor (SNRI), is used to treat various health conditions, including major depressive disorder, generalized anxiety disorder, fibromyalgia, and off-label for chemotherapy-induced pain. We conducted this systematic review and meta-analysis aiming to test the current evidence regarding effectiveness and safety of duloxetine for postspine surgeries pain.</p><p><strong>Methods: </strong>We searched the Cochrane Central Register of Controlled Trials, PubMed, Scopus and Web of science databases for relevant articles up to March 2024. The following search terms were Used in combination using the Boolean operators ((Duloxetine Hydrochloride) AND ((Pain, Postoperative) OR (Postoperative Period) OR (Postoperative Cognitive Complications) OR (Delayed Emergence from Anesthesia) OR (Postoperative Care) OR (spine surgery)) without time constrain for the search. Meta-analysis was performed using Review Manager (RevMan version 5.4) on the extracted outcome data that present in at least 3 of the included studies. Mean difference (MD) was used as the effect size for continuous outcomes with a 95% confidence interval (CI) or standardized mean difference (SMD) in case of different outcome reporting scales.</p><p><strong>Results: </strong>Pooled analysis showed that duloxetine significantly reduces pain intensity after 24 h from the operation compared to placebo (SMD = -1.11, 95% CI [-2.16 to -0.07], p = 0.04) with no significant difference in pain after 2 and 48 h. Meta-analysis revealed that duloxetine shows a significant reduction in the amount of analgesic consumption after 24 h postoperative; (MD = -3.33, 95% CI [-5.53 to -1.13], p = 0.003). The analysis did not show any statistically significant difference between duloxetine and placebo in patients experiencing nausea or vomiting (RR = 1.37, 95% CI [0.62 to 3.00] CONCLUSION: The findings of this study suggest that duloxetine may be effective in reducing pain 24 h after spine surgery. Furthermore, there is a promising effect of duloxetine in treating chronic postoperative pain. However, it is important to acknowledge that further research is warranted to thoroughly evaluate the efficacy and safety of duloxetine for relieving chronic postoperative pain.</p>","PeriodicalId":9081,"journal":{"name":"Brain and Behavior","volume":"15 1","pages":"e70217"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11688044/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142909191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fardin Nabizadeh, Shadi Sheykhlou, Sara Mahmoodi, Elham Khalili, Rasa Zafari, Helia Hosseini
Background: Previous studies on neuroimaging findings in Alzheimer's disease (AD) patients with hallucinations and delusions have yielded inconsistent results. We aimed to systematically review neuroimaging findings of delusions and hallucinations in AD patients to describe the most prominent neuroimaging features.
Methods: We performed a comprehensive search in three online databases, including PubMed, Scopus, and Web of Science in June 2023. We included studies that reported neuroimaging features of AD patients with delusion, hallucination, or psychosis.
Results: After the screening, 34 studies with 2241 AD patients were eligible to be included in our qualitative synthesis. On the basis of the included studies, there are significant changes in the volume and perfusion levels of broad brain areas, including the hippocampus, amygdala, insula, cingulate, occipital, frontal, prefrontal, orbitofrontal, temporal, and parietal cortices in these patients. Moreover, AD patients with psychosis, hallucinations, or delusions reflected different EEG waves compared to AD patients without these disorders.
Conclusion: The results of our review provided evidence about the neuroimaging alterations in AD patients suffering from psychosis, hallucinations, and delusions using different imaging methods. AD patients with psychosis, hallucinations, or delusions have significant differences in the volume and perfusion levels of various brain regions along with alterations in EEG waves and biological molecules compared to patients with only AD.
背景:以往关于阿尔茨海默病(AD)患者幻觉和妄想的神经影像学研究结果不一致。我们的目的是系统地回顾阿尔茨海默病患者妄想和幻觉的神经影像学表现,以描述最突出的神经影像学特征。方法:我们于2023年6月在PubMed、Scopus和Web of Science三个在线数据库中进行了全面的检索。我们纳入了报道AD患者伴有妄想、幻觉或精神病的神经影像学特征的研究。结果:筛选后,34项研究2241例AD患者符合纳入我们的定性综合。在纳入的研究基础上,这些患者的海马、杏仁核、岛叶、扣带、枕叶、额叶、前额叶、眶额叶、颞叶和顶叶皮质等广泛脑区体积和灌注水平均有显著变化。此外,伴有精神病、幻觉或妄想的AD患者与没有这些疾病的AD患者相比,反映出不同的脑电图。结论:本研究结果为不同影像学方法对伴有精神病、幻觉和妄想的AD患者的神经影像学改变提供了证据。伴有精神病、幻觉或妄想的AD患者与单纯AD患者相比,在脑各区域的容量和灌注水平以及脑电图和生物分子的改变上存在显著差异。
{"title":"Neuroimaging Findings of Psychosis in Alzheimer's Disease: A Systematic Review.","authors":"Fardin Nabizadeh, Shadi Sheykhlou, Sara Mahmoodi, Elham Khalili, Rasa Zafari, Helia Hosseini","doi":"10.1002/brb3.70205","DOIUrl":"10.1002/brb3.70205","url":null,"abstract":"<p><strong>Background: </strong>Previous studies on neuroimaging findings in Alzheimer's disease (AD) patients with hallucinations and delusions have yielded inconsistent results. We aimed to systematically review neuroimaging findings of delusions and hallucinations in AD patients to describe the most prominent neuroimaging features.</p><p><strong>Methods: </strong>We performed a comprehensive search in three online databases, including PubMed, Scopus, and Web of Science in June 2023. We included studies that reported neuroimaging features of AD patients with delusion, hallucination, or psychosis.</p><p><strong>Results: </strong>After the screening, 34 studies with 2241 AD patients were eligible to be included in our qualitative synthesis. On the basis of the included studies, there are significant changes in the volume and perfusion levels of broad brain areas, including the hippocampus, amygdala, insula, cingulate, occipital, frontal, prefrontal, orbitofrontal, temporal, and parietal cortices in these patients. Moreover, AD patients with psychosis, hallucinations, or delusions reflected different EEG waves compared to AD patients without these disorders.</p><p><strong>Conclusion: </strong>The results of our review provided evidence about the neuroimaging alterations in AD patients suffering from psychosis, hallucinations, and delusions using different imaging methods. AD patients with psychosis, hallucinations, or delusions have significant differences in the volume and perfusion levels of various brain regions along with alterations in EEG waves and biological molecules compared to patients with only AD.</p>","PeriodicalId":9081,"journal":{"name":"Brain and Behavior","volume":"15 1","pages":"e70205"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11688121/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142909259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: Despite the increasing interest in positive psychology and the functional characteristics of one of its practical derivations, strength-based parenting, there is a paucity of information regarding the assessment tools for strength-based parenting and their psychometric properties. Thus, this study aimed to translate the Strength-Based Parenting Scale (SBPS) into Persian and investigate its validity and reliability among Iranian adolescents.
Method: Of the 645 adolescents who completed the Persian translation of the SBPS (349 females, Mage = 14.01 years, SDage = 0.82, range = 13-15), 300 also answered the Mental Toughness Scale for Adolescents and the Connor-Davidson Resilience Scale.
Finding: Confirmatory factor analysis supported a two-factor structure comprising dimensions of "knowledge of strengths" and "use of strengths," the measurement invariance of which was established across sexes and school grades. The two dimensions were significantly and strongly correlated with the constructs of mental toughness and psychological resilience (r = 0.36-0.65, p < 0.01), corroborating the criterion-related validity of the SBPS. Furthermore, excellent internal consistency coefficients were observed for both subscales (0.96-0.97).
Conclusion: Our findings substantiate the positions derived from positive psychology, upon which the conceptual foundation of strength-based parenting is built, and provide preliminary support for the psychometric properties of the Persian version of the SBPS.
{"title":"Psychometric Properties of the Persian Version of the Strength-Based Parenting Scale in an Adolescent Sample.","authors":"Ahmad Asgarizadeh, Omid Shokri","doi":"10.1002/brb3.70213","DOIUrl":"10.1002/brb3.70213","url":null,"abstract":"<p><strong>Purpose: </strong>Despite the increasing interest in positive psychology and the functional characteristics of one of its practical derivations, strength-based parenting, there is a paucity of information regarding the assessment tools for strength-based parenting and their psychometric properties. Thus, this study aimed to translate the Strength-Based Parenting Scale (SBPS) into Persian and investigate its validity and reliability among Iranian adolescents.</p><p><strong>Method: </strong>Of the 645 adolescents who completed the Persian translation of the SBPS (349 females, M<sub>age</sub> = 14.01 years, SD<sub>age</sub> = 0.82, range = 13-15), 300 also answered the Mental Toughness Scale for Adolescents and the Connor-Davidson Resilience Scale.</p><p><strong>Finding: </strong>Confirmatory factor analysis supported a two-factor structure comprising dimensions of \"knowledge of strengths\" and \"use of strengths,\" the measurement invariance of which was established across sexes and school grades. The two dimensions were significantly and strongly correlated with the constructs of mental toughness and psychological resilience (r = 0.36-0.65, p < 0.01), corroborating the criterion-related validity of the SBPS. Furthermore, excellent internal consistency coefficients were observed for both subscales (0.96-0.97).</p><p><strong>Conclusion: </strong>Our findings substantiate the positions derived from positive psychology, upon which the conceptual foundation of strength-based parenting is built, and provide preliminary support for the psychometric properties of the Persian version of the SBPS.</p>","PeriodicalId":9081,"journal":{"name":"Brain and Behavior","volume":"15 1","pages":"e70213"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11688050/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142909262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zhihui Xu, Cong Liu, Peng Wang, Xing Wang, Yuzhang Li
<p><strong>Background: </strong>Systematic Review of The effects of exercise on inhibitory function interventions for patients with major depressive disorder.</p><p><strong>Methods: </strong>We searched PubMed, Web of Science, EMbase, The Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang Database, and China Science and Technology Journal Database (CQVIP) for randomized controlled trials (RCTs) investigating the impact of exercise on inhibitory function in MDD patients, from database inception to July 2024. Two researchers independently evaluated the quality of the included studies using the Risk of Bias (ROB 2.0) tool. Evidence quality was assessed with the GRADE profiler software, and effect sizes were combined using Stata 17.0 software to create forest plots, test for publication bias, and perform sensitivity analyses.</p><p><strong>Results: </strong>A total of nine RCTs involving 1038 participants from six countries, published between 2001 and 2022, were included. The average age of participants in both the experimental and control groups was 45 years. Meta-analysis results indicated that exercise significantly improves inhibitory function in MDD patients, with a combined effect size (SMD = 0.48, 95% CI = 0.18-0.77, p < 0.001). Subgroup analysis showed that exercise had a statistically significant effect on inhibitory control in MDD patients, with an effect size (SMD = 0.563, p < 0.001). Regarding exercise elements, other types of exercise (resistance exercise RE, mixed exercise ME), duration greater than 45 min, intervention period of ≤12 weeks, frequency of two times per week, and low intensity were found to be more effective, all with statistical significance (SMD = 0.863, p < 0.001; SMD = 0.936, p < 0.001; SMD = 0.525, p = 0.002; SMD = 0.682, p = 0.004; SMD = 0.94, p = 0.00).</p><p><strong>Conclusion: </strong>Based on the International Classification of Diseases (ICD) and the Diagnostic and Statistical Manual of Mental Disorders (DSM) classification systems, a research framework for exercise interventions on executive function in MDD patients was constructed, demonstrating that exercise can improve inhibitory function in MDD with high evidence quality. Our study found that other types of exercise (RE or ME), intervention duration of >45 min, intervention period of ≤12 weeks, frequency of two times per week, and low intensity are more effective for improving inhibitory function in MDD patients. While the overall methodological quality of the literature was good, high heterogeneity existed among studies. Subgroup analysis suggested that sources of heterogeneity included measurement tools, exercise types, exercise intensity, duration, and frequency. Sensitivity analysis indicated that exercise duration and period might be causes of heterogeneity. This study has some limitations as the included literature did not consider disease duration, depression severity, or categorize age groups. However, the findings provide str
背景:运动对重度抑郁症患者抑制功能干预效果的系统综述。方法:检索PubMed、Web of Science、EMbase、Cochrane Library、中国知网(CNKI)、万方数据库和中国科技期刊数据库(CQVIP),从数据库建立到2024年7月,检索调查运动对MDD患者抑制功能影响的随机对照试验(RCTs)。两名研究人员使用风险偏倚(ROB 2.0)工具独立评估纳入研究的质量。使用GRADE profiler软件评估证据质量,使用Stata 17.0软件合并效应量,创建森林图,检验发表偏倚,并进行敏感性分析。结果:共纳入了2001年至2022年间发表的9项随机对照试验,涉及来自6个国家的1038名参与者。实验组和对照组参与者的平均年龄都是45岁。meta分析结果显示,运动可显著改善MDD患者的抑制功能,其综合效应大小(SMD = 0.48, 95% CI = 0.18-0.77, p < 0.001)。亚组分析显示,运动对MDD患者抑制控制有统计学意义,效应量(SMD = 0.563, p < 0.001)。在运动要素方面,其他类型运动(阻力运动RE、混合运动ME)、持续时间大于45 min、干预时间≤12周、频率为每周2次、低强度更有效,均有统计学意义(SMD = 0.863, p < 0.001);SMD = 0.936, p < 0.001;SMD = 0.525, p = 0.002;SMD = 0.682, p = 0.004;SMD = 0.94, p = 0.00)。结论:基于国际疾病分类(ICD)和精神障碍诊断与统计手册(DSM)分类系统,构建了运动干预MDD患者执行功能的研究框架,表明运动可以改善MDD患者的抑制功能,证据质量高。我们的研究发现,其他类型的运动(RE或ME),干预时间为bb0 ~ 45 min,干预时间≤12周,频率为每周2次,低强度对改善MDD患者抑制功能更有效。虽然文献的整体方法学质量良好,但研究之间存在高度异质性。亚组分析表明,异质性的来源包括测量工具、运动类型、运动强度、持续时间和频率。敏感性分析表明,运动时长和运动时间可能是导致异质性的原因。这项研究有一些局限性,因为纳入的文献没有考虑疾病持续时间、抑郁严重程度或年龄组。然而,这些发现为临床实践和未来研究运动对MDD患者抑制功能的有益影响提供了强有力的证据。试验注册:CRD42023480371。
{"title":"The Effects of Exercise on Inhibitory Function Interventions for Patients With Major Depressive Disorder (MDD): A Systematic Review and Meta-Analysis.","authors":"Zhihui Xu, Cong Liu, Peng Wang, Xing Wang, Yuzhang Li","doi":"10.1002/brb3.70178","DOIUrl":"10.1002/brb3.70178","url":null,"abstract":"<p><strong>Background: </strong>Systematic Review of The effects of exercise on inhibitory function interventions for patients with major depressive disorder.</p><p><strong>Methods: </strong>We searched PubMed, Web of Science, EMbase, The Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang Database, and China Science and Technology Journal Database (CQVIP) for randomized controlled trials (RCTs) investigating the impact of exercise on inhibitory function in MDD patients, from database inception to July 2024. Two researchers independently evaluated the quality of the included studies using the Risk of Bias (ROB 2.0) tool. Evidence quality was assessed with the GRADE profiler software, and effect sizes were combined using Stata 17.0 software to create forest plots, test for publication bias, and perform sensitivity analyses.</p><p><strong>Results: </strong>A total of nine RCTs involving 1038 participants from six countries, published between 2001 and 2022, were included. The average age of participants in both the experimental and control groups was 45 years. Meta-analysis results indicated that exercise significantly improves inhibitory function in MDD patients, with a combined effect size (SMD = 0.48, 95% CI = 0.18-0.77, p < 0.001). Subgroup analysis showed that exercise had a statistically significant effect on inhibitory control in MDD patients, with an effect size (SMD = 0.563, p < 0.001). Regarding exercise elements, other types of exercise (resistance exercise RE, mixed exercise ME), duration greater than 45 min, intervention period of ≤12 weeks, frequency of two times per week, and low intensity were found to be more effective, all with statistical significance (SMD = 0.863, p < 0.001; SMD = 0.936, p < 0.001; SMD = 0.525, p = 0.002; SMD = 0.682, p = 0.004; SMD = 0.94, p = 0.00).</p><p><strong>Conclusion: </strong>Based on the International Classification of Diseases (ICD) and the Diagnostic and Statistical Manual of Mental Disorders (DSM) classification systems, a research framework for exercise interventions on executive function in MDD patients was constructed, demonstrating that exercise can improve inhibitory function in MDD with high evidence quality. Our study found that other types of exercise (RE or ME), intervention duration of >45 min, intervention period of ≤12 weeks, frequency of two times per week, and low intensity are more effective for improving inhibitory function in MDD patients. While the overall methodological quality of the literature was good, high heterogeneity existed among studies. Subgroup analysis suggested that sources of heterogeneity included measurement tools, exercise types, exercise intensity, duration, and frequency. Sensitivity analysis indicated that exercise duration and period might be causes of heterogeneity. This study has some limitations as the included literature did not consider disease duration, depression severity, or categorize age groups. However, the findings provide str","PeriodicalId":9081,"journal":{"name":"Brain and Behavior","volume":"15 1","pages":"e70178"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11686088/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142909266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}